NA
Nirav Amitkumar Chokshi
About Nirav Amitkumar Chokshi
Data last updated:
Nirav Amitkumar Chokshi is a Director at Isazi Pharma And Techno Consultancy Private Limited (since 2023), Director at Isazi Analytical Services Private Limited (since 2022) and Director at Isazi Investment Corporation Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Business Outsourcing, Research & Development and Telecommunication. The 4 current companies with reported revenue have a combined latest revenue of ₹2.80 Cr; the largest is Isazi Pharma And Techno Consultancy Private Limited at ₹2.78 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Isazi Pharma And Techno Consultancy Private Limited U74999GJ2018PTC101764 | Director | 21 Jun 2023 | 2018 | ₹2.78 Cr (FY 2024) | Active |
 Isazi Analytical Services Private Limited U73200GJ2022PTC134149 | Director | 21 Jul 2022 | 2022 | ₹1.5 Lakh (FY 2024) | Active |
| Isazi Investment Corporation Private Limited U64200GJ2023PTC138843 | Director | 23 Feb 2023 | 2023 | ₹94,510 (FY 2025) | Active |
| Health Quotient Insights Private Limited U72900GJ2022PTC133362 | Director | 28 Jun 2022 | 2022 | ₹6,606 (FY 2024) | Active |
| Isazi Business Growth Partners Private Limited U70200GJ2026PTC183743 | Non- Individual Subscriber | 16 Sep 2026 | 2026 | Active | |
| Voxtur International Private Limited U46497GJ2024PTC147673 | Director | 12 Jan 2024 | 2024 | Active |
Board colleagues of Nirav Amitkumar Chokshi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirav Amitkumar Chokshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirav Amitkumar Chokshi
Nirav Amitkumar Chokshi currently holds 6 directorships: Isazi Pharma And Techno Consultancy Private Limited (Director, since 21 Jun 2023, revenue ₹2.78 Cr (FY 2024)); Isazi Analytical Services Private Limited (Director, since 21 Jul 2022, revenue ₹1.5 Lakh (FY 2024)); Isazi Investment Corporation Private Limited (Director, since 23 Feb 2023, revenue ₹94,510 (FY 2025)); Health Quotient Insights Private Limited (Director, since 28 Jun 2022, revenue ₹6,606 (FY 2024)); Isazi Business Growth Partners Private Limited (Non- Individual Subscriber, since 16 Sep 2026); and 1 more.
Nirav Amitkumar Chokshi was first appointed on 28 Jun 2022 as Director at Health Quotient Insights Private Limited. The most recent appointment on record is 16 Sep 2026 at Isazi Business Growth Partners Private Limited.
The 4 current companies of Nirav Amitkumar Chokshi that report revenue have a combined latest revenue of ₹2.80 Cr: Isazi Pharma And Techno Consultancy Private Limited ₹2.78 Cr (FY 2024); Isazi Analytical Services Private Limited ₹1.5 Lakh (FY 2024); Isazi Investment Corporation Private Limited ₹94,510 (FY 2025); Health Quotient Insights Private Limited ₹6,606 (FY 2024).
The current boards of Nirav Amitkumar Chokshi's companies include Rupal Nirav Chokshi (Isazi Pharma And Techno Consultancy Private Limited), Vijaykumar Prabhudas Satapara (Isazi Pharma And Techno Consultancy Private Limited), Mahin Dineshbhai Patel (Isazi Analytical Services Private Limited), Shailendra Pratapbhai Bhalgama (Isazi Analytical Services Private Limited), Shaileshkumar Kantilal Patel (Isazi Analytical Services Private Limited), Shreyaskumar Patel (Isazi Analytical Services Private Limited), among others.